Sitari Pharmaceuticals' Series A Round

Sitari Pharmaceuticals raised a round of funding on November 22, 2013.

Sitari Pharma is developing treatments for celiac disease, an autoimmune digestive disease caused by intolerance to gluten, a protein found in wheat, rye and barley that damages the small intestine an…

Articles about Sitari Pharmaceuticals' Series A Round: